Udit Batra

As President and CEO of Waters Corporation, Dr. Batra brings more than two decades of leadership and operational expertise in the healthcare and life sciences industries. He has a proven track record leading multi-billion-dollar global organizations and driving results at the top of the industry.

Before joining Waters in September 2020, Dr. Batra served as CEO of the $7.7 billion life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada. In 2015, Dr. Batra led the formation of MilliporeSigma, with the largest merger in the life science tools industry at the time. Dr. Batra led the team that oversaw a strategic and operational transformation of the business that drove record sales growth and margin development. From 2011-2013, as CEO of Merck KGaA’s consumer health business, Dr. Batra led a period which saw doubling of the business’ profitability and achieving organic growth in the top tier of the industry.

Earlier in his career, Dr. Batra served in a range of leadership positions at Novartis, a Swiss multinational pharmaceutical company. In addition to leading Corporate Strategy and Global Public Health and Market Access for Vaccines and Diagnostics, he also served as president of the Australia Pharma business. During his tenure, this subsidiary became the fastest-growing business amongst competitors in Australia and in Novartis. Throughout his career, Dr. Batra has championed science education, especially for low-income students, developed and promoted women’s leadership, and has been a strong advocate for increasing diversity across the organizations he has led.

Dr. Batra has received numerous leadership accolades and recognition, including being named 2020 New Englander of the Year by the New England Council, 2019 NECA Business Person of the Year, Pharmavoice Top 100 Most Inspirational People (2017-2019), Boston Business Journal’s 2019 Power 50 and the 2016 CPhl Pharma CEO of the Year.

Currently, Dr. Batra is the Chairman of the Massachusetts High Tech Council and is a member of the Board at both the Boston Chamber of Commerce and MassBio. He serves on the Advisory Council of the chemical engineering departments of Princeton University and University of Delaware, where he also earned both a Ph.D. and a B.S. in chemical engineering, respectively.